US 11833159
Non-hormonal steroid modulators of NF-kB for treatment of disease
granted A61KA61K31/57A61K31/573
Quick answer
US patent 11833159 (Non-hormonal steroid modulators of NF-kB for treatment of disease) held by ReveraGen BioPharma, Inc. expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ReveraGen BioPharma, Inc.
- Grant date
- Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/57, A61K31/573, A61K31/575, A61P